[Long-term survival of malignant fibrous histiocytoma of the chest wall by multidisciplinary treatment].

Abstract

We report a case of malignant fibrous histiocytoma (MFH) of the chest wall. A 70-year-old man admitted for recurrent chest wall tumor diagnosed for MFH histologically and resected 7 months and 13 months before admission. Chest computed tomography (CT) revealed a tumor located at right posterior chest wall. In May 1997, resection of the tumor was done (the 3rd operation), but metastasis to the ribs (the 4th operation), subcutaneous tissue (the 5th operation), and local recurrence (the 6th operation) was found within 4 years postoperatively. Resection was done for each metastasis, and postoperative radiotherapy (66 Gy) and chemotherapy (CYVADIC) were done. The patient is doing well without apparent recurrence 57 months after last surgery, and survives 113 months after initial surgery. Multidisciplinary treatment may provide longer survival for patients with MFH of the chest wall.

• Authors: Iwao Kitazono, H Saigenji
• Journal: Kyobu geka. The Japanese journal of thoracic surgery (Kyobu Geka) Vol. 60 Issue 3 Pg. 221-4 (Mar 2007) ISSN: 0021-5252 [Print] Japan
• PMID: 17352141 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Vincristine
• Dacarbazine
• Doxorubicin
• Cyclophosphamide

Topics

• Aged
• Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
• Combined Modality Therapy
• Cyclophosphamide (administration & dosage)
• Dacarbazine (administration & dosage)
• Doxorubicin (administration & dosage)
• Drug Administration Schedule
• Histiocytoma, Malignant Fibrous (drug therapy, radiotherapy, surgery, therapy)
• Humans
• Male
• Radiotherapy Dosage
• Surgical Mesh
• Survivors
• Thoracic Neoplasms (drug therapy, radiotherapy, surgery, therapy)
• Vincristine (administration & dosage)